Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
201 studies found for:    "Herpes Simplex"
Show Display Options
Rank Status Study
1 Not yet recruiting Herpes Simplex Reactivation in Adult Critical Care Patients
Conditions: Herpes Simplex I;   Herpes Simplex II
Intervention: Other: No intervention will be performed
2 Completed Structure of the Herpes Simplex Virus Receptor
Conditions: Encephalitis;   Herpes Simplex;   Keratitis;   Mouth Disease;   Skin Disease
Intervention:
3 Completed Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
Condition: Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK208141;   Biological: Placebo injection
4 Completed
Has Results
Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth
Condition: Herpes Simplex
Interventions: Drug: Acyclovir;   Drug: Placebo
5 Completed The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK)
Condition: Herpes Simplex Keratitis
Intervention:
6 Completed Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS
Conditions: Herpes Simplex;   HIV Infections
Intervention: Drug: Cidofovir
7 Completed Valaciclovir to Prevent Transmission of Herpes Simplex Virus
Condition: Herpes Simplex
Intervention: Drug: Valaciclovir
8 Completed Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-Positive Adults
Condition: Prophylaxis Herpes Simplex
Intervention: Biological: Herpes simplex candidate (gD) vaccine GSK208141
9 Completed The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood
Conditions: Herpes Simplex;   HIV Infections
Intervention: Drug: Acyclovir
10 Completed Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old
Condition: Herpes Simplex
Interventions: Biological: GSK208141;   Biological: HavrixTM (investigational formulation);   Biological: Placebo
11 Completed Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine GSK208141 - non-MPL-containing adjuvant;   Biological: Herpes simplex candidate vaccine GSK208141- MPL-containing adjuvant
12 Completed Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141;   Biological: Herpes simplex virus containing gD-Alum
13 Completed
Has Results
Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection
Condition: Herpes Simplex
Intervention: Drug: Famciclovir
14 Withdrawn The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children
Conditions: Herpes Simplex;   HIV Infections;   Chickenpox
Intervention: Drug: Valacyclovir hydrochloride
15 Completed SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir
Conditions: Herpes Simplex;   HIV Infections
Intervention: Drug: Crofelemer
16 Completed An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies
Conditions: Herpes Simplex;   HIV Infections
Intervention: Drug: Foscarnet sodium
17 Completed The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment
Conditions: Herpes Simplex;   HIV Infections
Intervention: Drug: Foscarnet sodium
18 Completed An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies
Conditions: Herpes Simplex;   HIV Infections
Intervention: Drug: Foscarnet sodium
19 Completed Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine
Condition: Herpes Simplex
Intervention: Biological: GSK208141 vaccine
20 Completed A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS
Conditions: Herpes Simplex;   HIV Infections
Intervention: Drug: Cidofovir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years